Pharma-Bio Serv (PBSV) Total Debt (2020 - 2021)

Pharma-Bio Serv (PBSV) posted Total Debt of $1.9 million for Q2 2021, little changed on a QoQ basis from $1.9 million in Q1 2021, and little changed year-over-year from $1.9 million in Q2 2020.

Pharma-Bio Serv (PBSV) Total Debt (2020 - 2021) Analysis & Trends

Pharma-Bio Serv's Total Debt history runs 2 years deep, the most recent figure standing at $1.9 million for Q2 2021.

  • Quarterly Total Debt changed 0.0% year-over-year to $1.9 million in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $1.9 million (changed 0.0% YoY) and the FY2020 annual result came in at $1.9 million, changed N/A from the prior year.
  • Total Debt was $1.9 million for Q2 2021 at Pharma-Bio Serv, roughly flat from $1.9 million in the prior quarter.
  • Across five years, Total Debt topped out at $1.9 million in Q2 2020 and bottomed at $1.9 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Veeva Systems 31.97 Bn 24.65 Bn 662.02 Mn -
2 BrightSpring Health Services 14.72 Bn 13.82 Bn 482.22 Mn 2.50 Bn
3 Healthequity 8.31 Bn 8.05 Bn 256.31 Mn 942.66 Mn
4 Hinge Health 5.99 Bn 5.68 Bn 154.23 Mn -
5 10x Genomics 5.92 Bn 5.38 Bn 106.18 Mn -
6 MiniMed 4.54 Bn 4.24 Bn 480.00 Mn -
7 Waystar Holding 4.48 Bn 4.42 Bn 216.84 Mn 1.47 Bn
8 Doximity 3.96 Bn 3.21 Bn 125.97 Mn -
9 Privia Health 3.15 Bn 2.73 Bn - -
10 Pharma-Bio Serv 13.28 Mn 4.81 Mn 902,041.00 -

Historic Data

Download Data
DateValue
Apr 30, 2021 1.93 Mn
Jan 31, 2021 1.93 Mn
Oct 31, 2020 1.93 Mn
Jul 31, 2020 1.93 Mn
Apr 30, 2020 1.93 Mn